Back
ESC Premium Access

Cholesterol metabolism and the role of PCSK9

Session: PCSK9 inhibition - cholesterol reduction and beyond
Topic: Lipids (Epidemiology and Prevention)
Speaker: Professor S. Nicholls (Melbourne, AU)
Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor Stephen Nicholls

Monash University, Melbourne (Australia)
51 presentations
4 followers

3 more presentations in this session

A global view: the rationale for aggresive LDL lowering

Speaker: Professor S. Nissen (Cleveland, US)

Access
Slides
Video
Thumbnail

Show me the data: clinical efficacy, safety and indications of PCSK9 inhibition

Speaker: Professor J. Jukema (Leiden, NL)

Access
Slides
Video
Thumbnail

Are there effects of PCSK9 inhibitors beyond cholesterol lowering?

Speaker: Professor B. Cariou (Nantes, FR)

Access
Slides
Video
Thumbnail

Access the full session

PCSK9 inhibition - cholesterol reduction and beyond

Speakers: Professor S. Nicholls, Professor S. Nissen, Professor J. Jukema, Professor B. Cariou
Access
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb